1. Home
  2. IBRX vs MTDR Comparison

IBRX vs MTDR Comparison

Compare IBRX & MTDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$7.35

Market Cap

7.2B

Sector

Health Care

ML Signal

HOLD

MTDR

Matador Resources Company

HOLD

Current Price

$50.50

Market Cap

6.3B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
IBRX
MTDR
Founded
2014
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
6.3B
IPO Year
2015
2011

Fundamental Metrics

Financial Performance
Metric
IBRX
MTDR
Price
$7.35
$50.50
Analyst Decision
Strong Buy
Buy
Analyst Count
7
15
Target Price
$12.57
$63.07
AVG Volume (30 Days)
11.7M
1.6M
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
2.38%
EPS Growth
38.71
N/A
EPS
N/A
N/A
Revenue
$113,288,000.00
$3,696,277,000.00
Revenue This Year
$88.59
$7.15
Revenue Next Year
$131.15
$7.63
P/E Ratio
N/A
N/A
Revenue Growth
668.31
5.46
52 Week Low
$1.95
$37.14
52 Week High
$12.43
$66.84

Technical Indicators

Market Signals
Indicator
IBRX
MTDR
Relative Strength Index (RSI) 51.85 37.73
Support Level $6.69 $40.78
Resistance Level $8.54 $57.65
Average True Range (ATR) 0.40 1.74
MACD 0.04 -0.31
Stochastic Oscillator 89.02 18.73

Price Performance

Historical Comparison
IBRX
MTDR

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

About MTDR Matador Resources Company

Matador Resources Co is an independent energy company engaged in the exploration, development, production, and acquisition of oil and natural gas resources. The majority of the company's assets are located in the United States, with an emphasis on oil and natural gas shale and other unconventional plays. Along with maintaining a portfolio of oil and natural gas properties, Matador works to identify and develop midstream opportunities that support and enhance its exploration and development business. The Company has two reportable business segments: exploration and production and midstream. The company generates majority of its revenue from the exploration and production segment.

Share on Social Networks: